INS and diabetes mellitus: The estimated global prevalence of diabetes mellitus (DM), a metabolic disorder characterized by blood sugar and insulin dysregulation [1, 2], has an estimated global prevalence of approximately 9%, and by 2030, 300–400 million people will likely be affected worldwide [3], resulting in significant economic and social hardships [4, 5].